Clinical Quick Reference — Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology
This guideline establishes Appropriate Use Criteria (AUC) for initial transthoracic echocardiography (TTE) in outpatient pediatric cardiology. It covers 113 distinct clinical indications across 9 major categories, rated as Appropriate (A), May Be Appropriate (M), or Rarely Appropriate (R).
Palpitations are common in children and adolescents. TTE appropriateness depends heavily on associated symptoms, ECG findings, and family history. This section covers 16 distinct clinical scenarios.
| Clinical Scenario | AUC Rating |
|---|---|
| Palpitations with no other symptoms or signs of cardiovascular disease, benign family history, and no recent ECG | R(2) |
| Palpitations with no other symptoms or signs, benign family history, and normal ECG | A(1) |
| Palpitations with abnormal ECG | A(6) |
| Palpitations with family history of a channelopathy | A(3) |
| Palpitations in patient with known channelopathy | A(4) |
| Palpitations with family history at young age (<50 years) of sudden cardiac arrest or death | A(7) |
| Palpitations with family history of cardiomyopathy | A(9) |
| Palpitations in patient with known cardiomyopathy | A(9) |
| PACs in prenatal or neonatal period | A(3) |
| PACs after neonatal period | A(3) |
| Supraventricular tachycardia | A(7) |
| PVCs in prenatal or neonatal period | M(6) |
| PVCs after neonatal period | M(6) |
| Ventricular tachycardia | A(9) |
| Sinus bradycardia | R(2) |
| Sinus arrhythmia | A(1) |
Syncope in children can result from benign vasovagal causes or life-threatening cardiac arrhythmias. TTE appropriateness depends on symptom characteristics, ECG findings, and family history of sudden cardiac death or inherited conditions.
| Clinical Scenario | AUC Rating |
|---|---|
| Syncope with or without palpitations and with no recent ECG | A(3) |
| Syncope with no other symptoms or signs, benign family history, and normal ECG | R(2) |
| Syncope with abnormal ECG | A(7) |
| Syncope with family history of channelopathy | A(5) |
| Syncope with family history at young age of sudden cardiac arrest or death | A(9) |
| Syncope with family history of cardiomyopathy | A(9) |
| Probable neurocardiogenic (vasovagal) syncope | R(2) |
| Unexplained pre-syncope | M(4) |
| Exertional syncope | A(9) |
| Unexplained post-exertional syncope | A(7) |
| Syncope with known non-cardiovascular cause | A(2) |
Chest pain in children is usually benign. Most cases are musculoskeletal or anxiety-related. However, family history, symptom characteristics, and ECG findings guide the need for TTE.
| Clinical Scenario | AUC Rating |
|---|---|
| Chest pain with no other symptoms or signs, benign family history, and normal ECG | R(2) |
| Chest pain with other symptoms or signs, benign family history, and normal ECG | M(6) |
| Exertional chest pain | A(8) |
| Non-exertional chest pain with no recent ECG | A(3) |
| Non-exertional chest pain with normal ECG | A(1) |
| Non-exertional chest pain with abnormal ECG | A(7) |
| Chest pain with family history of sudden unexplained death or cardiomyopathy | A(8) |
| Chest pain with family history of premature coronary artery disease | M(4) |
| Chest pain with recent onset of fever | M(6) |
| Reproducible chest pain with palpation or deep inspiration | A(1) |
| Chest pain with recent illicit drug use | M(6) |
A murmur detected on auscultation is one of the most common reasons for referral to pediatric cardiology. However, the vast majority of murmurs in children are innocent. TTE appropriateness depends on whether the murmur is presumptuously innocent or suggestive of pathology.
| Clinical Scenario | AUC Rating |
|---|---|
| Presumptively innocent murmur with no symptoms, signs, or findings and benign family history | A(1) |
| Presumptively innocent murmur with symptoms, signs, or findings of cardiovascular disease | A(7) |
| Pathologic murmur | A(9) |
Innocent murmurs are soft, systolic murmurs (grade 2/6 or less) in early or early-mid systole with crescendo-decrescendo quality. They vary with position and lack clicks, diastolic components, or abnormal heart sounds.
Pathologic murmurs include continuous murmurs, holosystolic murmurs, late systolic murmurs, grade 3/6 or louder murmurs, diastolic murmurs, or murmurs provoked by Valsalva or postural change.
Beyond the four most common presentations (palpitations, syncope, chest pain, murmur), several other symptoms and signs warrant TTE evaluation.
| Clinical Scenario | AUC Rating |
|---|---|
| Symptoms suggestive of congestive heart failure (respiratory distress, poor perfusion, feeding difficulty, edema, hepatomegaly) | A(9) |
| Chest wall deformities and scoliosis pre-operatively | M(6) |
| Fatigue with no other cardiac signs, normal ECG, and benign family history | R(3) |
| Cyanosis | A(8) |
| Signs of endocarditis without positive blood culture | A(8) |
| Unexplained fever without overt evidence for cardiovascular involvement | A(1) |
| Central cyanosis | A(8) |
| Isolated acyanosis | A(1) |
When non-echocardiographic testing (ECG, chest X-ray, genetic testing, serology) yields abnormal findings, TTE may be indicated for further characterization and risk stratification.
| Clinical Scenario | AUC Rating |
|---|---|
| Known channelopathy | M(4) |
| Genotype positive for cardiomyopathy | A(9) |
| Abnormal chest X-ray findings suggestive of cardiovascular disease | A(9) |
| Abnormal ECG without symptoms | A(7) |
| Desaturation based on pulse oximetry | A(9) |
| Previously normal echocardiogram with no change in status or family history | A(1) |
| Previously normal echocardiogram with change in status or new family history | A(7) |
| Elevated anti-streptolysin O titers without suspicion for rheumatic fever | R(3) |
| Chromosomal abnormality known to be associated with cardiovascular disease | A(9) |
| Chromosomal abnormality with undefined cardiovascular risk | M(6) |
| Positive blood cultures suggestive of infective endocarditis | A(9) |
| Abnormal cardiac biomarkers | A(9) |
| Abnormal barium swallow or bronchoscopy suggesting vascular ring | A(7) |
Many systemic diseases carry cardiac manifestations warranting initial TTE evaluation, including infectious, inflammatory, genetic, and metabolic conditions.
| Condition | AUC Rating |
|---|---|
| Cancer without chemotherapy | M(5) |
| Prior to or during chemotherapy in cancer | A(8) |
| Sickle cell disease and other hemoglobinopathies | A(8) |
| Connective tissue disorder such as Marfan, Loeys Dietz, and other aortopathy syndromes | A(9) |
| Suspected connective tissue disorder | A(7) |
| Clinically suspected syndrome or extracardiac congenital anomaly associated with congenital heart disease | A(9) |
| Human immunodeficiency virus infection | A(8) |
| Suspected or confirmed Kawasaki disease | A(9) |
| Suspected or confirmed Takayasu arteritis | A(9) |
| Suspected or confirmed acute rheumatic fever | A(9) |
| Systemic lupus erythematosus and autoimmune disorders | A(7) |
| Muscular dystrophy | A(9) |
| Systemic hypertension | A(9) |
| Renal failure | A(7) |
| Obesity without other cardiovascular risk factors | R(2) |
| Obesity with obstructive sleep apnea | M(6) |
| Obesity with other cardiovascular risk factors | M(6) |
| Diabetes mellitus | R(3) |
| Lipid disorders | R(3) |
| Stroke | A(8) |
| Seizures, other neurologic disorders, or psychiatric disorders | R(2) |
| Suspected pulmonary hypertension | A(9) |
| Gastrointestinal disorders, not otherwise specified | R(2) |
| Hepatic disorders | M(4) |
| Failure to thrive | M(5) |
| Storage diseases, mitochondrial and metabolic disorders | A(8) |
| Abnormalities of visceral or cardiac situs | A(9) |
A family history of sudden cardiac death, cardiomyopathy, channelopathy, or congenital heart disease in first-degree relatives warrants TTE screening even without symptoms.
| Family History Scenario | AUC Rating |
|---|---|
| Unexplained sudden death before age 50 years | M(6) |
| Premature coronary artery disease before age 50 years | R(2) |
| Channelopathy | A(3) |
| Hypertrophic cardiomyopathy | A(9) |
| Non-ischemic dilated cardiomyopathy | A(9) |
| Other cardiomyopathies | A(8) |
| Unspecified cardiovascular disease | R(3) |
| Disease at high risk for cardiovascular involvement | R(2) |
| Genetic disorder at high risk for cardiovascular involvement | A(7) |
| Marfan or Loeys Dietz syndrome | A(7) |
| Connective tissue disorder other than Marfan or Loeys Dietz | M(6) |
| Congenital left-sided heart lesion | M(6) |
| Congenital heart disease other than left-sided lesions | A(5) |
| Idiopathic pulmonary arterial hypertension | A(5) |
| Heritable pulmonary arterial hypertension | A(8) |
| Pulmonary arterial hypertension other than idiopathic and heritable | R(3) |
| Consanguinity | R(3) |
Neonates born to mothers with certain infections, metabolic conditions, or autoimmune diseases may have cardiac manifestations requiring evaluation.
| Maternal / Neonatal Scenario | AUC Rating |
|---|---|
| Suspected cardiovascular abnormality on fetal echocardiogram | A(9) |
| Isolated echogenic focus on fetal ultrasound | R(2) |
| Maternal infection during pregnancy or delivery with potential fetal/neonatal cardiac sequelae | A(7) |
| Maternal diabetes with no prior fetal echocardiogram | M(6) |
| Maternal diabetes with normal fetal echocardiogram | M(4) |
| Maternal phenylketonuria | A(7) |
| Maternal autoimmune disorder | A(5) |
| Maternal teratogen exposure | M(6) |
A panel of 15 pediatric cardiologists rated each of the 113 indications using a 9-point scale. The median score determined the final rating:
The number in parentheses reflects the median score for that specific indication.
The following calculators support clinical decision-making in pediatric cardiology, particularly for risk stratification in inherited conditions.
Calculate QTc and assess for prolongation. Essential for screening in LQTS, drug-induced QT prolongation, and electrolyte abnormalities.
Estimate 5-year sudden cardiac death risk in hypertrophic cardiomyopathy. Guides ICD implantation decisions and risk stratification in HCM family screening.